DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $898,800 | -4.8% | 3,745 | 0.0% | 0.80% | -10.1% |
Q1 2023 | $943,890 | -5.0% | 3,745 | 0.0% | 0.89% | -1.0% |
Q4 2022 | $993,998 | +2.8% | 3,745 | 0.0% | 0.90% | +0.4% |
Q3 2022 | $967,000 | +1.9% | 3,745 | 0.0% | 0.90% | +13.3% |
Q2 2022 | $949,000 | -13.6% | 3,745 | 0.0% | 0.79% | +16.2% |
Q1 2022 | $1,099,000 | -10.8% | 3,745 | 0.0% | 0.68% | +2.1% |
Q4 2021 | $1,232,000 | +8.1% | 3,745 | 0.0% | 0.67% | -0.7% |
Q3 2021 | $1,140,000 | +13.4% | 3,745 | 0.0% | 0.67% | +22.4% |
Q2 2021 | $1,005,000 | +19.2% | 3,745 | 0.0% | 0.55% | +11.2% |
Q1 2021 | $843,000 | +1.3% | 3,745 | 0.0% | 0.49% | -2.4% |
Q4 2020 | $832,000 | +3.2% | 3,745 | 0.0% | 0.50% | -16.7% |
Q3 2020 | $806,000 | +21.8% | 3,745 | 0.0% | 0.61% | +39.0% |
Q2 2020 | $662,000 | +27.8% | 3,745 | 0.0% | 0.44% | +23.9% |
Q1 2020 | $518,000 | -9.9% | 3,745 | 0.0% | 0.35% | +27.5% |
Q4 2019 | $575,000 | +6.3% | 3,745 | 0.0% | 0.28% | -3.8% |
Q3 2019 | $541,000 | +1.1% | 3,745 | 0.0% | 0.29% | +1.8% |
Q2 2019 | $535,000 | +8.3% | 3,745 | 0.0% | 0.28% | +5.2% |
Q1 2019 | $494,000 | +28.0% | 3,745 | 0.0% | 0.27% | +7.6% |
Q4 2018 | $386,000 | -5.2% | 3,745 | 0.0% | 0.25% | +14.7% |
Q3 2018 | $407,000 | +9.7% | 3,745 | -0.3% | 0.22% | +3.3% |
Q2 2018 | $371,000 | -11.9% | 3,756 | -12.7% | 0.21% | -15.3% |
Q1 2018 | $421,000 | +5.5% | 4,300 | 0.0% | 0.25% | +3.3% |
Q4 2017 | $399,000 | +8.1% | 4,300 | 0.0% | 0.24% | -1.2% |
Q3 2017 | $369,000 | +1.7% | 4,300 | 0.0% | 0.24% | 0.0% |
Q2 2017 | $363,000 | -80.8% | 4,300 | -80.5% | 0.24% | -81.1% |
Q1 2017 | $1,889,000 | +9.7% | 22,086 | -0.2% | 1.28% | +4.6% |
Q4 2016 | $1,722,000 | -1.1% | 22,126 | -0.4% | 1.23% | -5.8% |
Q3 2016 | $1,742,000 | -22.2% | 22,224 | +0.3% | 1.30% | -24.5% |
Q2 2016 | $2,238,000 | +5.1% | 22,154 | -1.3% | 1.73% | +9.4% |
Q1 2016 | $2,129,000 | +2.4% | 22,439 | +0.3% | 1.58% | +1.5% |
Q4 2015 | $2,079,000 | +7.1% | 22,383 | -1.7% | 1.56% | +3.7% |
Q3 2015 | $1,941,000 | +708.8% | 22,775 | +713.4% | 1.50% | +906.7% |
Q2 2015 | $240,000 | +0.8% | 2,800 | 0.0% | 0.15% | +4.9% |
Q1 2015 | $238,000 | -0.8% | 2,800 | 0.0% | 0.14% | +2.9% |
Q4 2014 | $240,000 | +12.7% | 2,800 | 0.0% | 0.14% | +10.4% |
Q3 2014 | $213,000 | -3.2% | 2,800 | 0.0% | 0.12% | -1.6% |
Q2 2014 | $220,000 | +4.8% | 2,800 | 0.0% | 0.13% | -0.8% |
Q1 2014 | $210,000 | -2.8% | 2,800 | 0.0% | 0.13% | -2.3% |
Q4 2013 | $216,000 | – | 2,800 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |